Dong H, He L, Sun Q, et al
These contraindications exist because the risks outweigh potential benefits
Complment alimentaire rtention deau et jambes lourdes Les jambes lourdes sont souvent associes une mauvaise circulation des fluides et une accumulation deau dans les tissus
Not addressing your weight now has a high cost
If your progress has stalled, you should consult with your healthcare provider rather than adding over-the-counter medications
Tirzepatide may be favored when: Maximum weight loss is the primary goal and cost/insurance isn't a barrier A patient has type 2 diabetes and would benefit from tirzepatide's strong glycemic effects A patient didn't achieve adequate results on semaglutide Semaglutide may be favored when: Cost or insurance coverage strongly favors semaglutide A patient's prescriber has a longer track record of clinical experience with the drug (semaglutide has been used clinically for weight loss for longer) A patient tolerates GLP-1-only therapy well and doesn't need the added GIP effect Neither may be appropriate when: A patient has a personal or family history of medullary thyroid carcinoma or MEN2 syndrome A patient is pregnant, breastfeeding, or planning pregnancy soon A patient has a history of pancreatitis or certain GI conditions, without further evaluation A doctor or obesity-medicine specialist will weigh medical history, current medications, lab work, weight-loss goals, and cost before recommending either drug and will monitor treatment over time, adjusting the plan as needed
